Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Screening for systemic AL amyloidosis in patients >60 with λ monoclonal gammopathies may help develop a likelihood algorithm for AL using dFLC, IGVL gene usage, and the presence of t(11;14) or gain 1q as key factors.”
Title: Screening for Systemic Light-Chain Amyloidosis in Patients Over 60 with λ Monoclonal Gammopathies
Authors: Ping Zhou, Mahesh M Mansukhani, Raymond Yeh, Jiesheng Lu, Hongai Xia, Lahari Koganti, Jiuhong Pang, Denis Toskic, Stephanie Scalia, Xun Ma, Lisa X Lee, Sandy W Wong, Alfred Chung, Sascha A Tuchman, Terry Fogaren, Nancy Coady Lyons, Cindy Varga, Suzanne Lentzsch, Raymond L Comenzo
You can read the Full Article in the Journal of Clinical Medicine.
More posts featuring Robert Orlowski.
